Literature DB >> 7052113

Linear IgA disease in adults.

J N Leonard, G P Haffenden, N P Ring, R M McMinn, A Sidgwick, J F Mowbray, D J Unsworth, E J Holborow, W K Blenkinsopp, A F Swain, L Fry.   

Abstract

A multi-centre study is described in which thirty-five adult patients with papillary IgA dermatitis herpetiformis (DH) were compared with forty-two patients with linear IgA deposits, of whom thirty-four had homogeneous-linear (HL) and eight had granular-linear (GL) IgA deposits. The three groups were similar with regard to age of onset, presence of circulating immune complexes and auto-antibodies, incidence of spontaneous remission, histology of lesional skin and response to dapsone. There was a female predominance in the HL group in contrast to the male predominance in the other two. It was not possible to diagnose the HL group clinically. Some patients had a rash typical of DH whilst others resembled pemphigoid. In the majority, however, no specific diagnosis could be made with confidence. The GL group clinically resembled the DH group. The incidence of positive potassium iodide patch tests was greater in the DH group than in the other two. An associated enteropathy was found in 24% of patients in the HL group, 30% of patients in the GL group and 85% of patients in the DH group. Fifty-six percent of HL patients had HLA-B8 compared with 50% in the GL group and 88% in the DH group. Patients with linear IgA deposits may not be a uniform group, but until they can be divided into specific subgroups (e.g. by ultrastructural localization of the deposit or by response to a gluten-free diet) we propose that the term adult linear IgA diseases should be used to distinguish these patients from those with papillary IgA deposits.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7052113     DOI: 10.1111/j.1365-2133.1982.tb00360.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.

Authors:  J J Zone; T B Taylor; D P Kadunce; L J Meyer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Normal IgA production by peripheral blood lymphocytes in dermatitis herpetiformis and linear IgA dermatosis.

Authors:  F Wojnarowska; S Perl
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Dapsone therapy for the acute inflammatory phase of ocular pemphigoid.

Authors:  A I Fern; J L Jay; H Young; R MacKie
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

5.  Ultrastructural localization of binding sites of sera from patients with linear IgA bullous dermatosis.

Authors:  C Kowalewski; M Haftek; S Jablonska; D Schmitt
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Linear IgA disease and oesophageal carcinoma.

Authors:  S T Green; S Natarajan
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

7.  Increased risk of lymphoma in dermatitis herpetiformis.

Authors:  W F Tucker; J N Leonard; L Fry
Journal:  J R Soc Med       Date:  1983-02       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.